If you’ve been paying attention to the longevity space lately, you’ve probably noticed NAD+ popping up everywhere like a well-funded startup at a biotech conference. Unlike most wellness trends that seem to emerge from the collective imagination of Instagram influencers, NAD+ has something rather compelling going for it: actual science. Not just any science, but the kind that makes Nobel Prize winners take notice and pharmaceutical companies open their checkbooks.
Nicotinamide adenine dinucleotide—NAD+ for those of us who prefer our biochemistry without the tongue twisters—isn’t some newfangled discovery cooked up in a Silicon Valley lab. This molecular workhorse has been quietly running the show in every cell of your body since you were conceived, and frankly, it’s been doing a better job than most government agencies. The catch? Like a reliable employee nearing retirement, NAD+ levels decline with age, and when they do, things start to get interesting in all the wrong ways.
Continued on our Substack: https://blog.peptide.partners/p/nad-the-cellular-currency-thats-actually
Join our newsletter now!
© 2025 Peptide Partners
